Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Chédiak–Higashi syndrome: hematopoietic chimerism corrects genetic defect

Abstract

Chédiak–Higashi syndrome is a rare autosomal recessive disorder, primarily affecting neutrophils, and is often lethal by the third decade of life. Bone marrow transplantation is the only curative therapy currently available. This case describes a child undergoing a bone marrow transplant from a matched sibling donor, resulting in hematopoietic chimerism with only a small percentage of donor neutrophils found long term. The presence of a small percentage of donor neutrophils has resulted in normal development and no increased incidence of infections. Hematopoietic chimerism offers a cure with a potential reduction in the side-effects that result from marrow transplantation and the associated preparative therapies. Bone Marrow Transplantation (2001) 27, 1211–1213.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Miller DR, Baehner RL . Blood Diseases of Infancy and Childhood Mosby: St Louis 1995 pp 593–626

    Google Scholar 

  2. Jandl JH . Textbook of Hematology Little, Brown and Company: Boston 1996 pp 785–802

    Google Scholar 

  3. Haddad E, Le Deist F, Blanche S et al. Treatment of Chédiak–Higashi syndrome by allogeneic bone marrow transplantation: report of ten cases Blood 1995 85: 3328–3333

    CAS  PubMed  Google Scholar 

  4. Peters CP, Balthazor M, Shapiro EG et al. Outcome of unrelated donor bone marrow transplantation in forty children with Hurler syndrome Blood 1996 87: 4894–4902

    CAS  PubMed  Google Scholar 

  5. Storb R, Yu C, Wagner JL et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation Blood 1997 89: 3048–3054

    CAS  PubMed  Google Scholar 

  6. McSweeney PA, Storb R . Mixed chimerism: preclinical studies and clinical applications Biol Blood Marrow Transplant 1999 5: 192–203

    Article  CAS  PubMed  Google Scholar 

  7. Ortega M, Escudero T, Caballín MR et al. Follow-up of chimerism in children with hematological diseases after allogeneic hematopoietic progenitor cell transplants Bone Marrow Transplant 1999 24: 81–87

    Article  CAS  PubMed  Google Scholar 

  8. Coccia PF, Strandjord SE, Warkentin PI et al. High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission Blood 1988 71: 888–893

    CAS  PubMed  Google Scholar 

  9. Boxer LA, Watanabe AM, Rister M et al. Correction of leukocyte function in Chédiak–Higashi syndrome by ascorbate New Engl J Med 1976 295: 1041–1045

    Article  CAS  PubMed  Google Scholar 

  10. Barak Y, Nir E . Chédiak–Higashi syndrome Am J Ped Hematol Oncol 1987 9: 42–55

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trigg, M., Schugar, R. Chédiak–Higashi syndrome: hematopoietic chimerism corrects genetic defect. Bone Marrow Transplant 27, 1211–1213 (2001). https://doi.org/10.1038/sj.bmt.1703058

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703058

Keywords

Search

Quick links